RMD — ResMed Inc.
Is RMD overbought or oversold? Here is the current MarketMoodz read.
ResMed Inc. (RMD) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Medical Instruments & Supplies) last closed at $209.63. The rating moved from Oversold to Overbought on July 2, 2026 and has changed 22 times in the last 90 days.
- Public ratingOverbought (as of July 5, 2026)
- Last close$209.63
- Rating changesRating changed 22 times in the last 90 days
- Last changeMoved from Oversold to Overbought on July 2, 2026
- SectorHealthcare
- IndustryMedical Instruments & Supplies
Latest MarketMoodz coverage
- Disney outlines three-pillar growth plan: IP, AI, global reach2026-05-06
- Shilling warns of 2026 downturn amid housing stall and capex collapse2026-05-06
- Trump expands pre-deployment AI reviews with Google, Microsoft, xAI2026-05-05
- FBI Warns Banking Spoof Calls Draining Accounts Guidance for Banks and Customers2026-05-05
See today's live rating, score and targets
Members see the live hourly rating for RMD — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz